What This New Study Found Between Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and Stroke Risk A new cohort study published July 2025 in JAMA Network Open followed over 60,000 adults with both type 2 diabetes and obesity
When I was in residency, an older child psychiatrist told me that several extended-release formulations of methylphenidate had developed a reputation for not being effective
When its delivered intravenously, it bypasses the digestive process that breaks down most oral supplements before they ever reach the bloodstream, arriving at near-full strength
This is the single strongest piece of physiology behind the blend concept and, importantly, it is established GH physiology from controlled endocrine studies of the individual agents, not a validated finding about the specific CJC-1295 + Ipamorelin co-formulation